Cargando…

Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury

In the intratracheal bleomycin (ITB) model of acute lung injury (ALI), macrophages are recruited to the lung and participate in the inflammation and resolution that follows injury. Macrophage origin is influential in determining activation; however, the specific phenotype of recruited and resident m...

Descripción completa

Detalles Bibliográficos
Autores principales: Golden, Thea N., Venosa, Alessandro, Gow, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822172/
https://www.ncbi.nlm.nih.gov/pubmed/35145401
http://dx.doi.org/10.3389/fphar.2021.761496
_version_ 1784646559590252544
author Golden, Thea N.
Venosa, Alessandro
Gow, Andrew J
author_facet Golden, Thea N.
Venosa, Alessandro
Gow, Andrew J
author_sort Golden, Thea N.
collection PubMed
description In the intratracheal bleomycin (ITB) model of acute lung injury (ALI), macrophages are recruited to the lung and participate in the inflammation and resolution that follows injury. Macrophage origin is influential in determining activation; however, the specific phenotype of recruited and resident macrophages is not known. Inducible nitric oxide synthase (iNOS) has been implicated in the pathogenesis of ALI; however, the effects of its inhibition are mixed. Here we examined how macrophage origin determines the phenotypic response to ALI. Further, we hypothesize cell specific iNOS is key to determining activation and recruitment. Using a chimeric mouse approach, we have identified recruited and resident macrophage populations. We also used the chimeric mouse approach to create either pulmonary or bone marrow NOS2(−/−) mice and systemically inhibited iNOS via 1400 W. We evaluated macrophage populations at the peak of inflammation (8 days) and the beginning of resolution (15 days) following ITB. These studies demonstrate tissue resident macrophages adopt a M2 phenotype specifically, but monocyte originated macrophages activate along a spectrum. Additionally, we demonstrated that monocyte originating macrophage derived iNOS is responsible for recruitment to the lung during the inflammatory phase. Further, we show that macrophage activation is dependent upon cellular origin. Finally, these studies suggest pulmonary derived iNOS is detrimental to the lung following ITB. In conclusion, macrophage origin is a key determinant in response to ALI and iNOS is central to recruitment and activation.
format Online
Article
Text
id pubmed-8822172
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88221722022-02-09 Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury Golden, Thea N. Venosa, Alessandro Gow, Andrew J Front Pharmacol Pharmacology In the intratracheal bleomycin (ITB) model of acute lung injury (ALI), macrophages are recruited to the lung and participate in the inflammation and resolution that follows injury. Macrophage origin is influential in determining activation; however, the specific phenotype of recruited and resident macrophages is not known. Inducible nitric oxide synthase (iNOS) has been implicated in the pathogenesis of ALI; however, the effects of its inhibition are mixed. Here we examined how macrophage origin determines the phenotypic response to ALI. Further, we hypothesize cell specific iNOS is key to determining activation and recruitment. Using a chimeric mouse approach, we have identified recruited and resident macrophage populations. We also used the chimeric mouse approach to create either pulmonary or bone marrow NOS2(−/−) mice and systemically inhibited iNOS via 1400 W. We evaluated macrophage populations at the peak of inflammation (8 days) and the beginning of resolution (15 days) following ITB. These studies demonstrate tissue resident macrophages adopt a M2 phenotype specifically, but monocyte originated macrophages activate along a spectrum. Additionally, we demonstrated that monocyte originating macrophage derived iNOS is responsible for recruitment to the lung during the inflammatory phase. Further, we show that macrophage activation is dependent upon cellular origin. Finally, these studies suggest pulmonary derived iNOS is detrimental to the lung following ITB. In conclusion, macrophage origin is a key determinant in response to ALI and iNOS is central to recruitment and activation. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8822172/ /pubmed/35145401 http://dx.doi.org/10.3389/fphar.2021.761496 Text en Copyright © 2022 Golden, Venosa and Gow. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Golden, Thea N.
Venosa, Alessandro
Gow, Andrew J
Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title_full Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title_fullStr Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title_full_unstemmed Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title_short Cell Origin and iNOS Function Are Critical to Macrophage Activation Following Acute Lung Injury
title_sort cell origin and inos function are critical to macrophage activation following acute lung injury
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822172/
https://www.ncbi.nlm.nih.gov/pubmed/35145401
http://dx.doi.org/10.3389/fphar.2021.761496
work_keys_str_mv AT goldenthean celloriginandinosfunctionarecriticaltomacrophageactivationfollowingacutelunginjury
AT venosaalessandro celloriginandinosfunctionarecriticaltomacrophageactivationfollowingacutelunginjury
AT gowandrewj celloriginandinosfunctionarecriticaltomacrophageactivationfollowingacutelunginjury